Search - tctmd.com

Displaying 321 - 340 of 461

Sort: Relevancy | Date

News Industry News

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

October 29, 2013

News Conference News TCT 2013

Memories of TCT from the Beginning: Martin B. Leon, MD

October 29, 2013

News Conference News TCT 2013

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

October 29, 2013

News Industry News

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

October 29, 2013

Presentation TCT 2013

Meeting Appropriateness Criteria and Quality Metrics in Today's Cath Lab

Presenter: Peter Duffy

October 28, 2013

News Industry News

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

October 28, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Marvin L. Woodall

October 28, 2013

News Conference News TCT 2013

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

October 28, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Industry News

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

October 28, 2013

News Daily News

SCAI Paper Outlines ‘Best Practices’ for Radial Access

Caitlin E. Cox

October 25, 2013

News Industry News

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

October 17, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Conference News ESC 2013

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

September 09, 2013

News Daily News

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

July 19, 2013

News Industry News

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

June 14, 2013

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

Advertisement

New Study Compares Two Newer Generation Drug-Eluting Stents with Biocompatible and Biodegradable Polymers

Memories of TCT from the Beginning: Martin B. Leon, MD

In Memoriam: Andreas Gruentzig, MD, Receives TCT Career Achievement Award

Clinical Trial Finds That Corevalve Reduces Rate of Death and Stroke in Sickest Patients with Aortic Stenosis

Meeting Appropriateness Criteria and Quality Metrics in Today's Cath Lab

META-ANALYSIS DEMONSTRATES REDUCTION IN MORTALITY WITH PCI COMPARED TO MEDICAL THERAPY IN STABLE PATIENTS SELECTED ON THE BASIS OF ISCHEMIA

Memories of TCT 1988 and Beyond: Marvin L. Woodall

Debate Continues on Use of Heart Teams for High-Risk Patients with Heart Valve Disease

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

Anti-Clotting Agent Helps Reduce the Risk of Intraprocedural Events during Percutaneous Coronary Intervention

SCAI Paper Outlines ‘Best Practices’ for Radial Access

Medtronic to Unveil CoreValve U.S. Pivotal Trial Results at TCT 2013

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

ESC Congress 2013: Mix of Trials with Potential to Reshape Practice

COURAGE: Medical Therapy ‘Crossovers’ Have More Symptoms, not More Hard Events

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content